Valeritas Holdings, Inc. (NASDAQ:VLRX) was downgraded by analysts at ValuEngine from a “sell” rating to a “strong sell” rating in a research note issued to investors on Wednesday, July 19th.
A number of other research analysts have also recently issued reports on VLRX. B. Riley reissued a “buy” rating and set a $10.00 price target on shares of Valeritas Holdings in a research report on Wednesday, May 17th. Wedbush assumed coverage on shares of Valeritas Holdings in a research report on Monday, July 10th. They set an “outperform” rating and a $12.00 price target for the company. Finally, Cowen and Company assumed coverage on shares of Valeritas Holdings in a research report on Monday, April 17th. They set an “outperform” rating for the company.
Shares of Valeritas Holdings (VLRX) opened at 5.30 on Wednesday. The stock’s 50 day moving average is $5.87 and its 200 day moving average is $14.34. The company’s market capitalization is $36.26 million. Valeritas Holdings has a 52-week low of $4.51 and a 52-week high of $50.00.
Valeritas Holdings (NASDAQ:VLRX) last issued its quarterly earnings results on Friday, May 12th. The company reported ($6.92) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($2.72) by $4.20. The company had revenue of $4.61 million for the quarter, compared to the consensus estimate of $4.64 million. Equities analysts expect that Valeritas Holdings will post ($8.23) EPS for the current year.
TRADEMARK VIOLATION WARNING: This piece was originally reported by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this piece on another website, it was illegally stolen and reposted in violation of US & international trademark and copyright law. The correct version of this piece can be read at https://stocknewstimes.com/2017/07/31/valeritas-holdings-inc-vlrx-stock-rating-lowered-by-valuengine-updated.html.
In other Valeritas Holdings news, insider John Edward Timberlake purchased 5,000 shares of the stock in a transaction that occurred on Wednesday, May 17th. The stock was bought at an average cost of $5.14 per share, with a total value of $25,700.00. Following the transaction, the insider now directly owns 23,037 shares in the company, valued at approximately $118,410.18. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Over the last three months, insiders have purchased 11,500 shares of company stock valued at $57,615. 1.20% of the stock is currently owned by corporate insiders.
An institutional investor recently bought a new position in Valeritas Holdings stock. HighTower Advisors LLC purchased a new position in shares of Valeritas Holdings, Inc. (NASDAQ:VLRX) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 27,400 shares of the company’s stock, valued at approximately $195,000. HighTower Advisors LLC owned 1.67% of Valeritas Holdings at the end of the most recent quarter. 11.65% of the stock is currently owned by institutional investors.
Valeritas Holdings Company Profile
Valeritas, Inc is a United States-based company, which is engaged in developing and commercializing treatment solutions that contribute to clinical outcomes for patients. The Company’s portfolio includes V-Go disposable insulin delivery device, which is distributed through retail pharmacy. Its V-Go delivers insulin at a continuous preset basal rate and bolus dosing for adults with Type 2 diabetes requiring insulin.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Valeritas Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeritas Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
